Ketamine Treatment for OCD

Latest medical review on: July 6th, 2026. Medically reviewed by Instructor in Psychiatry at Harvard Medical School and Lumin Health Co-founder, Chief Medical Officer Dr. Ben Yudkoff.

Ketamine therapy is an evidence-based, off-label treatment option for OCD that may reduce obsessive thoughts within hours to days for some people. At Lumin Health, it's provided as intramuscular (IM) ketamine, administered by psychiatric clinicians in a private, calm setting.

If you're living with OCD — intrusive thoughts that won't quiet down, rituals that eat hours of your day — and first-line treatments like SSRIs or exposure therapy haven't brought enough relief, ketamine may be worth exploring. This page covers what the research shows so far, how treatment works, and what it costs.

What the research shows about ketamine for OCD

Evidence so far in ketamine for OCD

The research on ketamine for OCD is earlier-stage than for depression or PTSD, but it's promising. In a randomized crossover trial, a single intravenous dose of ketamine produced rapid reductions in obsessions for some participants — effects visible within hours. Other studies have explored ketamine as an addition to exposure and response prevention (ERP) therapy, with early evidence it may help the work of therapy take hold. Reviews of ketamine and esketamine in OCD describe meaningful short-term symptom relief in a subset of people.

Emerging evidence is exactly that — emerging. Ketamine isn't a first-line OCD treatment, and it doesn't replace ERP or medication management. For some people whose symptoms persist after standard care, it may open a window where change becomes easier.

Stuck thought loops and a way to step outside them

OCD tends to run on a loop: a doubt or fear fires, a ritual briefly quiets it, and the loop tightens. Brain research links this cycle to over-active communication in circuits connecting the front of the brain to deeper structures — chemistry in which glutamate plays a central role.

During a ketamine session, many patients describe a sense of distance from their thoughts — room to observe the loop without being pulled through it. Some carry that perspective into daily practice afterward. What you do with the window matters as much as the medicine that opens it.

How ketamine works in the brain

Neuroplasticity: new connections beyond the loop

Ketamine acts on the brain's NMDA receptors, part of the glutamate system — the chemistry the brain uses for learning and change. This triggers a period of heightened neuroplasticity: a window in which new connections form more easily. Research also suggests ketamine may shift how large-scale brain networks regulate themselves, which may matter in OCD, where certain circuits are locked in over-communication. Your brain isn't broken — it may be stuck. Read more about ketamine and neuroplasticity.
Glutamate and the obsessive-compulsive cycle

Glutamate signaling appears to be out of balance in OCD, and ketamine works directly on that system — a different mechanism from standard medications, which act gradually on serotonin, norepinephrine, and dopamine. By modulating glutamate, ketamine may quiet the circuitry that keeps obsessions firing and support a more settled mood.

IM ketamine vs. esketamine (Spravato) for OCD

Esketamine (Spravato) is FDA-approved for treatment-resistant depression and for major depressive disorder with acute suicidal ideation — not for OCD. For OCD, Lumin Health clinicians use intramuscular (IM) ketamine: an evidence-based, off-label application of a medicine that's been in use for over 50 years. Off-label prescribing is common and legal when supported by clinical research — though it does affect insurance coverage, which we explain below.

OCD and depression frequently occur together. If you're experiencing both, esketamine (Spravato) may be an option for the depression side — often with insurance coverage — and our clinicians will walk you through which pathway fits your situation. Learn more about the differences between ketamine and esketamine.
If you’d like to explore how ketamine therapy or esketamine (Spravato) treatment could help you, book a complimentary consultation below. We look forward to speaking with you.

Insurance coverage and the cost of ketamine for OCD

Why coverage for OCD is limited

Because ketamine doesn't have an FDA-approved (on-label) indication for OCD, most commercial insurers don't cover IM ketamine for it. We're transparent about this up front: IM ketamine at Lumin Health is $500 per session, and we provide a Superbill — an itemized receipt — that patients with out-of-network PPO benefits can submit for potential partial reimbursement. Full details on our ketamine treatment cost page.
Making treatment accessible

We offer payment structures designed to minimize out-of-pocket spend while maximizing the chance treatment succeeds. And if you also have treatment-resistant depression, esketamine (Spravato) is covered by most major insurers we work with — check your plan on our insurance page or ask during your free consultation.

What to expect during ketamine treatment for OCD

Personalized Treatment Plans

It starts with a free consultation. Our psychiatric team — psychiatrists and psychiatric nurse practitioners, specifically trained in ketamine and esketamine — will review your symptoms, history, and goals, and build a plan around you. For most people, a course of 6-10 sessions over 3-5 weeks is enough to see meaningful results.
Safe and Comfortable Environment

Every session takes place in a private room with psychiatric care throughout. You'll be monitored the entire time, and our staff will make sure you feel settled, safe, and unhurried.
Positive Effects and Follow-Up

After the initial sessions, many patients describe quieter intrusive thoughts and less time lost to rituals — more of the day back in your hands. We track your progress together and adjust the plan as needed, with lasting relief as the goal.

How fast does ketamine work for OCD?

In research settings, people who responded noticed reduced obsessions within hours of a dose, with effects lasting days to about a week after a single treatment. That's why care is typically planned as a series of sessions with progress checks along the way.

Can ketamine treat OCD?

Emerging evidence suggests that, for some people, ketamine can produce rapid short-term reductions in obsessive thoughts, and it's being actively studied as an addition to ERP therapy. It isn't a first-line treatment and isn't right for everyone — our clinicians will be honest with you about fit.

Is ketamine FDA-approved for OCD?

No. Ketamine's only FDA-approved use is anesthesia; its use for OCD is off-label, supported by early clinical research. Esketamine (Spravato) is FDA-approved for treatment-resistant depression and major depressive disorder with acute suicidal ideation — not OCD.

Do I have to stop my current OCD treatment?

No — ketamine is typically explored alongside your existing care, not instead of it. Keep working with your prescriber, and if you're doing ERP with your own therapist, early research suggests ketamine may complement that work. We coordinate with you and your existing providers.

What about suicidal ideation (SI)? Can ketamine help with that?

Yes, ketamine has demonstrated potential in alleviating suicidal ideation, providing a lifeline to individuals experiencing the darkest moments of depression. However, if you are having active suicidal ideation, please do not wait - go to your nearest emergency room or mental health provider.
If you’d like to explore how ketamine therapy or esketamine (Spravato) treatment could help you, book a complimentary consultation below. We look forward to speaking with you.